Skip to main content
High RiskFDAfda-F-0781-2025UNDECLARED ALLERGEN

Peanut Butter 'N Fudge Ice Cream, 3 GAL, Wells Enterprises, INC dba Wells Dairy, Inc Le Mars, IA 51031, UPC: 070640050574, Item: 33429

Category
Units Affected
201
Recall Date
April 25, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2025.

Foreign material (plastic) may be present in ice cream product

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Wells Enterprises, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0781-2025.

Wells Enterprises, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Wells Enterprises, Inc. Recall FAQ

Wells Enterprises, Inc. is the subject of a dairy safety report: Peanut Butter 'N Fudge Ice Cream, 3 GAL, Wells Enterprises, INC dba Wells Dairy, Inc Le Mars, IA 51031, UPC: 070640050574, Item: 33429. The notice was published on April 25, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 201 units are potentially affected.